---
title: 酒石酸氢胆碱
description: 
published: true
date: 2026-01-30T09:47:37.231Z
tags: 
editor: markdown
dateCreated: 2026-01-30T06:00:52.515Z
---

[◀返回](/药物/home.md)

# 酒石酸氢胆碱



| 酒石酸氢胆碱 | |
| --- | --- |
| [![Choline.png](/文件/Choline.png)](/文件/Choline.png) | |
| 化学命名法 | |
| 俗名 | *胆碱* |
| 取代名称 | *胆碱* |
| 系统命名法 | *2\-Hydroxy\-N,N,N\-trimethylethan\-1\-aminium* |
| 类别成员 | |
| 精神活性分类 | *[益智药](/文档/药物分类/益智药.md "益智药")* |
| 化学分类 | *[铵盐](/文档/药物分类/铵盐.md "铵盐")* |
| [给药途径](/文档/给药途径.md "给药途径") | |
| - **警告:** 由于个体体重、耐受性、代谢和个人敏感度的差异，请务必从低剂量开始。[参见负责任的用药章节](/文档/负责任的用药索引页.md "负责任的用药")。 <br>   <br>    | ⇣ [口服](/文档/给药途径.md#口服 "给药途径") |
| [剂量](/文档/给药剂量.md "剂量") | |
| [生物利用度](/文档/给药剂量.md#Bioavailability "剂量") | 40% |
| [阈值](/文档/药物剂量分类.md#阈值 "药物剂量分类") | 50 mg |
| [轻微](/文档/药物剂量分类.md#轻微 "药物剂量分类") | 100 \- 250 mg |
| [中等](/文档/药物剂量分类.md#中等 "药物剂量分类") | 250 \- 1000 mg |
| [强烈](/文档/药物剂量分类.md#强烈 "药物剂量分类") | 1000 \- 2000 mg |
| [严重](/文档/药物剂量分类.md#严重 "药物剂量分类") | 2000 mg \+ |
| [药效时长](/文档/药效时长.md "药效时长") | |
| [总时长](/文档/药效时长.md#总时长 "药效时长") | 4 \- 8 小时 |
| [药效发作](/文档/药效时长.md#药效发作 "药效时长") | 45 \- 75 分钟 |
| [药效上升](/文档/药效时长.md#药效上升 "药效时长") | 15 \- 30 分钟 |
| [药效达峰](/文档/药效时长.md#药效达峰 "药效时长") | 2 \- 4 小时 |
| [药效褪去](/文档/药效时长.md#药效褪去 "药效时长") | 1 \- 2 小时 |
| [药效残余](/文档/药效时长.md#药效残余 "药效时长") | 2 \- 8 小时 |
| <br>   <br>   <br>   <br>   <br>   <br>   <br>   <br>    - **[免责声明](/关于本站/免责声明.md "免责声明"):** 本站的[剂量](/文档/给药剂量.md "剂量")信息收集自用户和[资源](/关于本站/资源.md "资源")，仅用于教育目的。这并非推荐，应与其他来源核实以确保准确性。 | |
| [相互作用](#Dangerous_interactions) | |
|  | |
|  | |
|  | |

**胆碱**是一种化学物质，在大脑中充当神经递质[乙酰胆碱](/文档/乙酰胆碱.md "乙酰胆碱")的前体。胆碱是人类必需的营养素，在降低神经管缺陷风险、脂肪肝和其他病理方面具有明确的作用。[\[1\]](#cite_note-Zeisel2009-1) 它还用于细胞膜成分的合成。[\[2\]](#cite_note-Glier2014-2) 胆碱很少以游离碱形式出售；为了稳定性，它通常与酸结合形成盐，如**酒石酸氢胆碱**，或结合成更复杂的形式之一，如[胞二磷胆碱](/药物/胞二磷胆碱.md "胞二磷胆碱")。

胆碱补充剂可用于治疗肝脏疾病、[\[3\]](#cite_note-3)[\[4\]](#cite_note-4) 肝炎、青光眼、[\[5\]](#cite_note-5) 动脉粥样硬化、阿尔茨海默病、[\[6\]](#cite_note-6) 双相情感障碍[\[7\]](#cite_note-7) 以及可能的其他神经系统疾病。[\[1\]](#cite_note-Zeisel2009-1) 研究还表明，它对患有酒精依赖症的人有积极影响。[\[8\]](#cite_note-8)[\[9\]](#cite_note-9)

据报道，当作为补充剂服用时，这种化合物会产生[益智](/文档/药物分类/益智药.md "益智药")效应。它很容易获得，通常通过在线补充剂供应商以此目的出售。

## 目录

* [1 化学](#化学)
* [2 药理学](#药理学)
* [3 主观效应](#主观效应)
    + [3\.1 **躯体效应**](#躯体效应)
    + [3\.2 **认知效应**](#认知效应)
    + [3\.3 体验报告](#体验报告)
* [4 毒性和危害潜力](#毒性和危害潜力)
    + [4\.1 耐受性和成瘾潜力](#耐受性和成瘾潜力)
* [5 法律地位](#法律地位)
* [6 外部链接](#外部链接)
* [7 文献](#文献)
* [8 参考资料](#参考资料)

## 化学

胆碱由季铵基团和醇官能团组成，它们通过乙基链连接。其带电荷的阳离子可以与负基团或原子结合形成各种盐，从而产生不同的效果。氯化胆碱可以与尿素形成一种具有不同寻常特性的低熔点低共熔溶剂混合物。[\[10\]](#cite_note-10) 常见的酒石酸氢胆碱是一种白色结晶粉末，熔点为 149\-153 °C。[\[11\]](#cite_note-11)

与其他盐形式一样，胆碱盐的质量并不完全是胆碱。对于酒石酸氢胆碱，其质量的 104\.17/253\.25 \= 41\.1% 是胆碱阳离子，其余是酒石酸氢根阴离子。对于按美国标签标准生产的补充剂，无需进行换算：给出的量就是胆碱的量。目前的营养学领域并未对非盐形式的胆碱（如磷脂形式和 Alpha\-GPC）应用类似的换算。[\[12\]](#cite_note-USDA_2008-12)

## 药理学

胆碱及其代谢物主要用于三个生理目的：

*   磷脂合成。胆碱是制造各种磷脂所必需的，磷脂构成了细胞膜和信号脂筏。[\[13\]](#cite_note-ze-13) 神经脂筏在精神病学领域越来越受到关注。[\[14\]](#cite_note-14)
*   胆碱能神经传递，作为[乙酰胆碱](/文档/乙酰胆碱.md "乙酰胆碱")合成的前体。[\[2\]](#cite_note-Glier2014-2) 补充胆碱可能使乙酰胆碱积累到比原本更高的水平。由于乙酰胆碱参与记忆功能，这可能解释了其[益智](/文档/药物分类/益智药.md "益智药")效应。\[*[来源请求](/关于本站/来源请求.md "来源请求")*\]
*   三甲胺 (甜菜碱) 的产生。三甲胺是渗透调节所必需的。它也参与[SAM\-e](/药物/SAM-e.md "SAM-e")的合成。[\[2\]](#cite_note-Glier2014-2)

## 主观效应

***免责声明：**以下列出的效应引用自[***主观效应索引***](/药效/home.md "主观效应索引") (**SEI**)，这是一个基于轶事用户报告和[PsychonautWiki](/关于本站/PsychonautWiki.md "PsychonautWiki") [贡献者](/关于本站/贡献者.md "贡献者")个人分析的开放研究文献。因此，应以健康的怀疑态度看待这些内容。*

*同样值得注意的是，这些效应不一定会以可预测或可靠的方式发生，尽管高剂量更容易诱发全方位的效应。*同样，**不良反应**随着剂量的增加变得越来越可能，并且可能包括**成瘾、严重伤害或死亡*** ☠.*

### **躯体效应** ![Child.png](/文件/Child.png)

*   **[刺激](/药效/刺激.md "刺激")** \- 胆碱表现出的刺激主要被认为是微妙的，弱于[咖啡因](/药物/咖啡因.md "咖啡因")。
*   **[头痛](/药效/头痛.md "头痛")**
*   **[体味改变](/药效/体味改变.md "体味改变")** \- 这种情况发生在某些人群中，尤其是那些患有三甲胺尿症的人。胆碱是三甲胺的前体，有些人无法轻易分解三甲胺，这通常会导致“鱼腥味”。[\[15\]](#cite_note-15)

### **认知效应** ![User.png](/文件/User.png)

*   **[促梦](/文档/药物分类/促梦剂.md "促梦")**

### 体验报告

目前的[体验索引](/报告/index.md "体验索引")中没有描述该化合物效应的轶事报告。其他的体验报告可以在这里找到：

*   [Erowid Experience Vaults: Choline](https://www.erowid.org/experiences/subs/exp_Vitamins_Choline.shtml)

## 毒性和危害潜力

由于胆碱是人体内天然存在的[乙酰胆碱](/文档/乙酰胆碱.md "乙酰胆碱")的天然前体，因此它具有良好的耐受性，不太可能以任何方式有害。胆碱不具有成瘾性，不造成脑损伤，且相对于剂量而言毒性极低。与许多其他[益智药](/文档/药物分类/益智药.md "益智药")物质类似，急性胆碱暴露相关的身体副作用相对较少。各种研究表明，在谨慎的背景下以合理的剂量使用，它不会产生任何类型的负面认知、精神或有毒的身体后果。

强烈建议在使用该物质时采取[伤害减少措施](/文档/负责任的用药索引页.md "负责任的用药")。

### 耐受性和成瘾潜力

胆碱不具有成瘾性，并且使用欲望实际上可能会随着使用而减少。它通常是自我调节的。

对胆碱效应的耐受性是在长期和重复使用后建立的。此后，大约需要 7 天耐受性才能减半，14 天才能恢复到基线（在没有进一步摄入的情况下）。胆碱与其他已知的化合物没有交叉耐受性，这意味着在摄入胆碱后，其他精神活性化合物的效果不会减弱。

## 法律地位

| ![Handcuffs-300px.png](/文件/Handcuffs-300px.png) | **本法律部分是一个[小节](/关于本站/小节.md "小节")。**<br>*因此，它可能包含不完整或错误的信息。您可以通过[扩展它](/关于本站/编辑指南.md)来提供帮助。* |
| --- | --- |

*   **德国**: 酒石酸氢胆碱是批准的膳食补充剂。[\[16\]](#cite_note-16)
*   **美国**: 在美国，胆碱作为膳食补充剂是合法的。美国食品和药物管理局 (FDA) 要求非乳制婴儿配方奶粉中必须含有胆碱。[\[17\]](#cite_note-17)

## 外部链接

*   [Choline (Wikipedia)](https://en.wikipedia.org/wiki/Choline)

## 文献

*   Abbott, A. P., Capper, G., Davies, D. L., Rasheed, R. K., & Tambyrajah, V. (2003). Novel solvent properties of choline chloride/urea mixtures. Chemical Communications, 99(1), 70–71. <https://doi.org/10.1039/b210714g>
*   Behari, J., Yeh, T.-H., Krauland, L., Otruba, W., Cieply, B., Hauth, B., … Monga, S. P. S. (2010). Liver-Specific B-Catenin Knockout Mice Exhibit Defective Bile Acid and Cholesterol Homeostasis and Increased Susceptibility to Diet-Induced Steatohepatitis. The American Journal of Pathology, 176(2), 744–753. <https://doi.org/10.2353/ajpath.2010.090667>
*   Chan, K. C., So, K. fai, & Wu, E. X. (2009). Proton magnetic resonance spectroscopy revealed choline reduction in the visual cortex in an experimental model of chronic glaucoma. Experimental Eye Research, 88(1), 65–70. <https://doi.org/10.1016/j.exer.2008.10.002>
*   Doggrell, S. a, & Evans, S. (2003). Treatment of dementia with neurotransmission modulation. Expert Opinion on Investigational Drugs, 12(10), 1633–54. <https://doi.org/10.1517/13543784.12.10.1633>
*   Glier, M. B., Green, T. J., & Devlin, A. M. (2014). Methyl nutrients, DNA methylation, and cardiovascular disease. Molecular Nutrition and Food Research, 58(1), 172–182. <https://doi.org/10.1002/mnfr.201200636>
*   Klatskin, G. (1954). the Effect of Alcohol on the Choline Requirement: Ii. Incidence of Renal Necrosis in Weanling Rats Following Short Term Ingestion of Alcohol. Journal of Experimental Medicine, 100(6), 615–627. <https://doi.org/10.1084/jem.100.6.615>
*   Nery, F. G., Stanley, J. A., Chen, H.-H., Hatch, J. P., Nicoletti, M. A., Serap Monkul, E., … Soares, J. C. (2010). Bipolar disorder comorbid with alcoholism: A 1H magnetic resonance spectroscopy study. Journal of Psychiatric Research, 44(5), 278–285. <https://doi.org/10.1016/j.jpsychires.2009.09.006>
*   Parnetti, L., Mignini, F., Tomassoni, D., Traini, E., & Amenta, F. (2007). Cholinergic precursors in the treatment of cognitive impairment of vascular origin: Ineffective approaches or need for re-evaluation? Journal of the Neurological Sciences, 257(1–2), 264–269. <https://doi.org/10.1016/j.jns.2007.01.043>
*   Stoll, A. L., Sachs, G. S., Cohen, B. M., Lafer, B., Christensen, J. D., & Renshaw, P. F. (1996). Choline in the treatment of rapid-cycling bipolar disorder: Clinical and neurochemical findings in lithium-treated patients. Biological Psychiatry, 40(5), 382–388. <https://doi.org/10.1016/0006-3223(95)00423-8>
*   Tolvanen, T., Yli-Kerttula, T., Ujula, T., Autio, A., Lehikoinen, P., Minn, H., & Roivainen, A. (2010). Biodistribution and radiation dosimetry of [11C]choline: A comparison between rat and human data. European Journal of Nuclear Medicine and Molecular Imaging, 37(5), 874–883. <https://doi.org/10.1007/s00259-009-1346-z>
*   Van Beek, A. H. E. A., & Claassen, J. A. H. R. (2011). The cerebrovascular role of the cholinergic neural system in Alzheimer’s disease. Behavioural Brain Research, 221(2), 537–542. <https://doi.org/10.1016/j.bbr.2009.12.047>
*   Zeisel, S. H., & Da Costa, K. A. (2009). Choline: An essential nutrient for public health. Nutrition Reviews, 67(11), 615–623. <https://doi.org/10.1111/j.1753-4887.2009.00246.x>

## 参考资料

1.  ↑ [1\.0](#cite_ref-Zeisel2009_1-0) [1\.1](#cite_ref-Zeisel2009_1-1) Zeisel, S. H., Costa, K.\-A. da (November 2009). ["Choline: an essential nutrient for public health"](https://academic.oup.com/nutritionreviews/article-lookup/doi/10.1111/j.1753-4887.2009.00246.x). *Nutrition Reviews*. **67** (11): 615–623. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10\.1111/j.1753\-4887\.2009\.00246\.x](//doi.org/10.1111%2Fj.1753-4887.2009.00246.x). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [0029\-6643](//www.worldcat.org/issn/0029-6643).
2.  ↑ [2\.0](#cite_ref-Glier2014_2-0) [2\.1](#cite_ref-Glier2014_2-1) [2\.2](#cite_ref-Glier2014_2-2) Glier, M. B., Green, T. J., Devlin, A. M. (January 2014). ["Methyl nutrients, DNA methylation, and cardiovascular disease"](https://onlinelibrary.wiley.com/doi/10.1002/mnfr.201200636). *Molecular Nutrition & Food Research*. **58** (1): 172–182. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10\.1002/mnfr.201200636](//doi.org/10.1002%2Fmnfr.201200636). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [1613\-4125](//www.worldcat.org/issn/1613-4125).
3.  [↑](#cite_ref-3) Tolvanen, T., Yli\-Kerttula, T., Ujula, T., Autio, A., Lehikoinen, P., Minn, H., Roivainen, A. (May 2010). ["Biodistribution and radiation dosimetry of \[11C\]choline: a comparison between rat and human data"](http://link.springer.com/10.1007/s00259-009-1346-z). *European Journal of Nuclear Medicine and Molecular Imaging*. **37** (5): 874–883. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10\.1007/s00259\-009\-1346\-z](//doi.org/10.1007%2Fs00259-009-1346-z). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [1619\-7070](//www.worldcat.org/issn/1619-7070).
4.  [↑](#cite_ref-4) Behari, J., Yeh, T.\-H., Krauland, L., Otruba, W., Cieply, B., Hauth, B., Apte, U., Wu, T., Evans, R., Monga, S. P. S. (February 2010). ["Liver\-Specific β\-Catenin Knockout Mice Exhibit Defective Bile Acid and Cholesterol Homeostasis and Increased Susceptibility to Diet\-Induced Steatohepatitis"](https://linkinghub.elsevier.com/retrieve/pii/S0002944010603884). *The American Journal of Pathology*. **176** (2): 744–753. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10\.2353/ajpath.2010\.090667](//doi.org/10.2353%2Fajpath.2010.090667). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [0002\-9440](//www.worldcat.org/issn/0002-9440).
5.  [↑](#cite_ref-5) Chan, K. C., So, K., Wu, E. X. (January 2009). ["Proton magnetic resonance spectroscopy revealed choline reduction in the visual cortex in an experimental model of chronic glaucoma"](https://linkinghub.elsevier.com/retrieve/pii/S0014483508003333). *Experimental Eye Research*. **88** (1): 65–70. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10\.1016/j.exer.2008\.10\.002](//doi.org/10.1016%2Fj.exer.2008.10.002). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [0014\-4835](//www.worldcat.org/issn/0014-4835).
6.  [↑](#cite_ref-6) Van Beek, A. H. E. A., Claassen, J. A. H. R. (August 2011). ["The cerebrovascular role of the cholinergic neural system in Alzheimer's disease"](https://linkinghub.elsevier.com/retrieve/pii/S016643281000015X). *Behavioural Brain Research*. **221** (2): 537–542. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10\.1016/j.bbr.2009\.12\.047](//doi.org/10.1016%2Fj.bbr.2009.12.047). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [0166\-4328](//www.worldcat.org/issn/0166-4328).
7.  [↑](#cite_ref-7) Stoll, A. L., Sachs, G. S., Cohen, B. M., Lafer, B., Christensen, J. D., Renshaw, P. F. (September 1996). ["Choline in the treatment of rapid\-cycling bipolar disorder: Clinical and neurochemical findings in lithium\-treated patients"](https://linkinghub.elsevier.com/retrieve/pii/0006322395004238). *Biological Psychiatry*. **40** (5): 382–388. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10\.1016/0006\-3223(95\)00423\-8](//doi.org/10.1016%2F0006-3223%2895%2900423-8). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [0006\-3223](//www.worldcat.org/issn/0006-3223).
8.  [↑](#cite_ref-8) Klatskin, G., Krehl, W. A. (1 December 1954). ["THE EFFECT OF ALCOHOL ON THE CHOLINE REQUIREMENT"](https://rupress.org/jem/article/100/6/615/2074/THE-EFFECT-OF-ALCOHOL-ON-THE-CHOLINE-REQUIREMENT). *Journal of Experimental Medicine*. **100** (6): 615–627. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10\.1084/jem.100\.6\.615](//doi.org/10.1084%2Fjem.100.6.615). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [1540\-9538](//www.worldcat.org/issn/1540-9538).
9.  [↑](#cite_ref-9) Nery, F. G., Stanley, J. A., Chen, H.\-H., Hatch, J. P., Nicoletti, M. A., Serap Monkul, E., Lafer, B., Soares, J. C. (April 2010). ["Bipolar disorder comorbid with alcoholism: A 1H magnetic resonance spectroscopy study"](https://linkinghub.elsevier.com/retrieve/pii/S0022395609002064). *Journal of Psychiatric Research*. **44** (5): 278–285. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10\.1016/j.jpsychires.2009\.09\.006](//doi.org/10.1016%2Fj.jpsychires.2009.09.006). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [0022\-3956](//www.worldcat.org/issn/0022-3956).
10. [↑](#cite_ref-10) Abbott, A. P., Capper, G., Davies, D. L., Rasheed, R. K., Tambyrajah, V. (19 December 2003). ["Novel solvent properties of choline chloride/urea mixturesElectronic supplementary information (ESI) available: spectroscopic data"](http://xlink.rsc.org/?DOI=b210714g). *Chemical Communications* (1): 70–71. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10\.1039/b210714g](//doi.org/10.1039%2Fb210714g). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [1359\-7345](//www.worldcat.org/issn/1359-7345).
11. [↑](#cite_ref-11) ["Choline bitartrate"](https://pubchem.ncbi.nlm.nih.gov/compound/Choline-bitartrate). Text " C9H19NO7" ignored ([help](/关于本站/编辑指南.md "Help:CS1 errors (page does not exist)")); Unknown parameter `|site=` ignored ([help](/关于本站/编辑指南.md "Help:CS1 errors (page does not exist)"))
12. [↑](#cite_ref-USDA_2008_12-0) ["USDA Database for the Choline Content of Common Foods, Release 2"](https://data.nal.usda.gov/dataset/usda-database-choline-content-common-foods-release-2-2008). *USDA Ag Data Commons* (in English). January 2008. Total choline content was calculated as the sum of Cho, GPC, Pcho, Ptdcho, and SM.
13. [↑](#cite_ref-ze_13-0) Rucker RB, Zempleni J, Suttie JW, McCormick DB (2007). [*Handbook of vitamins*![Free access subject to limited trial, subscription normally required](https://upload.wikimedia.org/wikipedia/commons/thumb/b/b4/Lock-blue-alt-2.png/langen-gb-20px-Lock-blue-alt-2.png.png "Free access subject to limited trial, subscription normally required")](https://archive.org/details/handbookvitamins00jzem) (4th ed.). Taylor & Francis. pp. [459](https://archive.org/details/handbookvitamins00jzem/page/n471)–477. [ISBN](http://en.wikipedia.org/wiki/International_Standard_Book_Number "wikipedia:International Standard Book Number") [9780849340222](http://en.wikipedia.org/wiki/Special:BookSources/9780849340222 "wikipedia:Special:BookSources/9780849340222").
14. [↑](#cite_ref-14) Wray, Nathan H.; Rasenick, Mark M. (2019). "Lipid rafts in psychiatry". *Advances in Pharmacology*. **86**: 21–45. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10\.1016/bs.apha.2019\.04\.001](//doi.org/10.1016%2Fbs.apha.2019.04.001).
15. [↑](#cite_ref-15) Kashyap, A. S. (1 May 2000). ["Fish odour syndrome"](https://pmj.bmj.com/lookup/doi/10.1136/pmj.76.895.318a). *Postgraduate Medical Journal*. **76** (895): 318a–3318. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10\.1136/pmj.76\.895\.318a](//doi.org/10.1136%2Fpmj.76.895.318a). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [0032\-5473](//www.worldcat.org/issn/0032-5473).
16. [↑](#cite_ref-16) BVL 2018/01/004 | <https://www.bvl.bund.de/DE/Arbeitsbereiche/01_Lebensmittel/04_AntragstellerUnternehmen/07_Allgemeinverfuegungen/01_Archiv_Uebersicht/07_Nahrungsergaenzungsmittel/lm_AV_BVL-18-01-004.pdf?__blob=publicationFile&v=3>
17. [↑](#cite_ref-17) United States Government Publishing Office (2017) <https://www.ecfr.gov/cgi-bin/text-idx?SID=10e89c74892c74350b79d3a4e51b1338&mc=true&node=se21.2.107_1100&rgn=div8>
